Zivo Bioscience, Inc. (ZIVO): Operating Cash Flow

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$4.31M
Year ended 2024-12-31
-$3.08M
Trailing 12 months to 2025-09-30
2010-12-31: -$1.44M2011-12-31: -$1.29M2012-12-31: -$1.77M2013-12-31: -$2.99M2014-12-31: -$2.74M2015-12-31: -$2.30M2016-12-31: -$2.54M2017-12-31: -$4.24M2018-12-31: -$5.01M2019-12-31: -$3.71M2020-12-31: -$2.59M2021-12-31: -$6.80M2022-12-31: -$7.10M2023-12-31: -$5.80M2024-12-31: -$4.31M-$4.31M
2010-12-31 Operating Cash Flow (USD) 2024-12-31
Period endedOperating Cash FlowChange YoYSource filing
2024-12-31-$4.31Mn/m2025-03-18, From 2024-01-01
2023-12-31-$5.80Mn/m2025-03-18, From 2023-01-01
2022-12-31-$7.10Mn/m2024-03-15, From 2022-01-01
2021-12-31-$6.80Mn/m2023-03-14, From 2021-01-01
2020-12-31-$2.59Mn/m2022-04-22, From 2020-01-01
2019-12-31-$3.71Mn/m2021-02-25, From 2019-01-01
2018-12-31-$5.01Mn/m2020-03-26, From 2018-01-01
2017-12-31-$4.24Mn/m2019-02-12, From 2017-01-01
2016-12-31-$2.54Mn/m2018-02-21, From 2016-01-01
2015-12-31-$2.30Mn/m2017-03-31, From 2015-01-02
2014-12-31-$2.74Mn/m2016-03-29, From 2014-01-02
2013-12-31-$2.99Mn/m2015-04-06, From 2013-01-02
2012-12-31-$1.77Mn/m2014-03-31, From 2012-01-02
2011-12-31-$1.29Mn/m2013-03-25, From 2011-01-01
2010-12-31-$1.44Mn/a2012-03-30, From 2010-01-02